Drug profile · INN
valbenazine tosylate
VALBENAZINE TOSYLATE
valbenazine tosylate (VALBENAZINE TOSYLATE) is a synaptic vesicular amine transporter inhibitor. Associated with NEUROCRINE BIOSCIENCES INC. Route of administration: oral. Current US regulatory status: approved.
Drug details — valbenazine tosylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 0
- Data quality
- 0.89
Quick answer
valbenazine tosylate (VALBENAZINE TOSYLATE) is a synaptic vesicular amine transporter inhibitor. Associated with NEUROCRINE BIOSCIENCES INC. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Synaptic vesicular amine transporter inhibitor
Primary target: Synaptic vesicular amine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12421193
GPR52 modulators and methods of use
granted -
US 11654142
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11439629
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11311532
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 11040029
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11026931
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11026939
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 10993941
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10952997
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10940141
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10912771
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10874648
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10857148
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10857137
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10851104
Valbenazine salts and polymorphs thereof
granted -
US 10851103
Valbenazine salts and polymorphs thereof
granted -
US 10844058
Valbenazine salts and polymorphs thereof
granted -
US 10065952
Valbenazine salts and polymorphs thereof
granted -
US 8357697
Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto
granted -
US 8039627
Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto
granted
Frequently asked questions
What is valbenazine tosylate?
valbenazine tosylate (VALBENAZINE TOSYLATE) is a synaptic vesicular amine transporter inhibitor. Associated with NEUROCRINE BIOSCIENCES INC. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for valbenazine tosylate?
VALBENAZINE TOSYLATE is a marketed brand name for valbenazine tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of valbenazine tosylate?
valbenazine tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.